[go: up one dir, main page]

NO890155L - Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.

Info

Publication number
NO890155L
NO890155L NO89890155A NO890155A NO890155L NO 890155 L NO890155 L NO 890155L NO 89890155 A NO89890155 A NO 89890155A NO 890155 A NO890155 A NO 890155A NO 890155 L NO890155 L NO 890155L
Authority
NO
Norway
Prior art keywords
indolpiperidin
compounds
procedure
preparation
therapeutic active
Prior art date
Application number
NO89890155A
Other languages
English (en)
Other versions
NO890155D0 (no
NO172539B (no
NO172539C (no
Inventor
Masaaki Matsuo
Takashi Manabe
Shinji Shigenaga
Hiroshi Matsuda
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888800795A external-priority patent/GB8800795D0/en
Priority claimed from GB888818260A external-priority patent/GB8818260D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO890155D0 publication Critical patent/NO890155D0/no
Publication of NO890155L publication Critical patent/NO890155L/no
Publication of NO172539B publication Critical patent/NO172539B/no
Publication of NO172539C publication Critical patent/NO172539C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO890155A 1988-01-14 1989-01-13 Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser NO172539C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888800795A GB8800795D0 (en) 1988-01-14 1988-01-14 New indolylpiperidine compounds processes for preparations thereof & pharmaceutical composition comprising same
GB888818260A GB8818260D0 (en) 1988-08-01 1988-08-01 New indolylpiperidine compounds processes for preparation thereof & pharmaceutical composition comprising same

Publications (4)

Publication Number Publication Date
NO890155D0 NO890155D0 (no) 1989-01-13
NO890155L true NO890155L (no) 1989-07-17
NO172539B NO172539B (no) 1993-04-26
NO172539C NO172539C (no) 1993-08-04

Family

ID=26293316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890155A NO172539C (no) 1988-01-14 1989-01-13 Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser

Country Status (16)

Country Link
US (2) US4935432A (no)
EP (1) EP0324431B1 (no)
JP (1) JPH0759577B2 (no)
KR (1) KR0130899B1 (no)
CN (1) CN1021733C (no)
AU (1) AU620583B2 (no)
CA (1) CA1336605C (no)
DE (1) DE68901039D1 (no)
DK (1) DK733788A (no)
ES (1) ES2032339T3 (no)
FI (1) FI91863C (no)
GR (1) GR3004987T3 (no)
HU (2) HU202224B (no)
IE (1) IE63476B1 (no)
IL (1) IL88903A (no)
NO (1) NO172539C (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
WO1996029075A1 (en) * 1995-03-20 1996-09-26 Eli Lilly And Company 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
US6458806B1 (en) * 1996-08-15 2002-10-01 Millennium Pharmaceuticals, Inc. Aryl alkenamides derivatives as MCP-1 antagonists
ES2165274B1 (es) 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
KR20010085555A (ko) * 1999-06-24 2001-09-07 히라이 가쯔히꼬 아드레날린 알파1비 수용체 길항약
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
US6803362B2 (en) 2001-03-09 2004-10-12 Ortho-Mcneil Pharmaceutical Inc. Heterocyclic compounds
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
AU2003274956A1 (en) * 2002-09-06 2004-03-29 Janssen Pharmaceutica, N.V. Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis
PL377087A1 (pl) 2002-09-06 2006-01-23 Janssen Pharmaceutica, N.V. Związki heterocykliczne

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2193584B1 (no) * 1972-07-28 1975-08-08 Roussel Uclaf
GB1425354A (en) * 1973-10-10 1976-02-18 Wyeth John & Brother Ltd Indole derivatives
FR2258843B1 (no) * 1974-01-30 1977-09-09 Roussel Uclaf
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2349331A1 (fr) * 1976-04-30 1977-11-25 Roussel Uclaf Nouveaux derives de 2,3 dihydro a/4-(3-indolyl) 1-piperidinyl/methyl 1,4-benzodioxin-2-methanol, un procede pour leur preparation et leur application comme medicaments
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
JPS57188567A (en) * 1981-05-13 1982-11-19 Fujimoto Seiyaku Kk Novel preparation of etomidoline
US4443461A (en) * 1981-09-10 1984-04-17 John Wyeth & Brother Limited N-[2-[[1-[1H-Indolylalkyl- or oxoalkyl]-4-piperidinyl]-amino]-2-oxoethyl]-arylcarboxamide derivatives
FR2533924A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant
JPS60142981A (ja) * 1983-12-28 1985-07-29 Yoshitomi Pharmaceut Ind Ltd 3−インド−ルカルボキサミド誘導体
US4673684A (en) * 1984-04-04 1987-06-16 Terumo Corporation Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4742057A (en) * 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8903036D0 (en) * 1989-02-10 1989-03-30 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
HU211485A9 (en) 1995-11-28
JPH0759577B2 (ja) 1995-06-28
DK733788A (da) 1989-07-15
DK733788D0 (da) 1988-12-30
IE890048L (en) 1989-07-14
KR0130899B1 (ko) 1998-04-23
CN1021733C (zh) 1993-08-04
NO890155D0 (no) 1989-01-13
EP0324431A1 (en) 1989-07-19
NO172539B (no) 1993-04-26
NO172539C (no) 1993-08-04
GR3004987T3 (no) 1993-04-28
JPH01221377A (ja) 1989-09-04
IL88903A0 (en) 1989-08-15
FI91863B (fi) 1994-05-13
AU2837089A (en) 1989-07-20
CA1336605C (en) 1995-08-08
FI890123L (fi) 1989-07-15
FI890123A0 (fi) 1989-01-11
IE63476B1 (en) 1995-04-19
ES2032339T3 (es) 1993-02-01
HU202224B (en) 1991-02-28
HUT49871A (en) 1989-11-28
CN1035112A (zh) 1989-08-30
DE68901039D1 (de) 1992-04-30
IL88903A (en) 1993-03-15
US5017703A (en) 1991-05-21
AU620583B2 (en) 1992-02-20
EP0324431B1 (en) 1992-03-25
FI91863C (fi) 1994-08-25
KR890011872A (ko) 1989-08-23
US4935432A (en) 1990-06-19

Similar Documents

Publication Publication Date Title
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO895086D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO894630L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO893616D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO890155L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.